Retinoids, breast cancer and NK cells

This publication has 10 references indexed in Scilit:

• Reduced natural killer cell activity and IL-2 production in malnourished cancer patients
  British Journal of Cancer, 1991
• Long-term tolerability of fenretinide (4-HPR) in breast cancer patients
  European Journal of Cancer and Clinical Oncology, 1991
• PLASMA RETINOL LEVEL REDUCTION BY THE SYNTHETIC RETINOID FENRETINIDE - A ONE-YEAR FOLLOW-UP-STUDY OF BREAST-CANCER PATIENTS
  1989
• Pharmacokinetics of n‐4‐hydroxyphenyl‐retinamide and the effect of its oral administration on plasma retinol concentrations in cancer patients
  International Journal of Cancer, 1989
• Natural killer cells, vitamins, and other blood components of vegetarian and omnivorous men
  Nutrition and Cancer, 1989
• N-(4-HYDROXYPHENYL)-ALL-TRANS-RETINAMIDE PHARMACOKINETICS IN FEMALE RATS AND MICE
  1986
• Effects of orally administered retinol on natural killer cell activity in wild type BALB/c and congenitally athymic BALB/c mice
  Cancer Immunology, Immunotherapy, 1986
• Fluctuations of NK activity in human volunteers receiving vitamin A or a placebo daily.
  1986
• Immunological aspects of retinoids in humans. III. Effects of retinoic acid on the natural killing of tumor cells.
  1985
• A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.
  The Journal of Immunology, 1981